These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy]. Maron MS Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172 [TBL] [Abstract][Full Text] [Related]
4. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside. Bogaert J; Olivotto I Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269 [TBL] [Abstract][Full Text] [Related]
5. Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update. Oliveira DC; Assunção FB; Santos AA; Nacif MS Arq Bras Cardiol; 2016 Aug; 107(2):163-72. PubMed ID: 27305111 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for hypertrophic cardiomyopathy update. Chan AK; Somarouthu B; Ghoshhajra B Top Magn Reson Imaging; 2014 Feb; 23(1):33-41. PubMed ID: 24509622 [TBL] [Abstract][Full Text] [Related]
7. MRI of hypertrophic cardiomyopathy: part I, MRI appearances. Hansen MW; Merchant N AJR Am J Roentgenol; 2007 Dec; 189(6):1335-43. PubMed ID: 18029869 [TBL] [Abstract][Full Text] [Related]
8. The role of cardiac magnetic resonance in hypertrophic cardiomyopathy. Duarte S; Bogaert J Rev Port Cardiol; 2010 Jan; 29(1):79-93. PubMed ID: 20391901 [TBL] [Abstract][Full Text] [Related]
9. Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. Nagueh SF; Mahmarian JJ J Am Coll Cardiol; 2006 Dec; 48(12):2410-22. PubMed ID: 17174177 [TBL] [Abstract][Full Text] [Related]
10. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances. Hansen MW; Merchant N AJR Am J Roentgenol; 2007 Dec; 189(6):1344-52. PubMed ID: 18029870 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699 [TBL] [Abstract][Full Text] [Related]
12. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management. Baxi AJ; Restrepo CS; Vargas D; Marmol-Velez A; Ocazionez D; Murillo H Radiographics; 2016; 36(2):335-54. PubMed ID: 26963450 [TBL] [Abstract][Full Text] [Related]
13. Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance. Ghio S; Revera M; Mori F; Klersy C; Raisaro A; Raineri C; Serio A; Pasotti M; Visconti LO Eur J Heart Fail; 2009 Oct; 11(10):952-7. PubMed ID: 19789398 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy. Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389 [TBL] [Abstract][Full Text] [Related]
15. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Schmidt GP; Kramer H; Reiser MF; Glaser C Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984 [TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796 [TBL] [Abstract][Full Text] [Related]
18. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Cardim N; Galderisi M; Edvardsen T; Plein S; Popescu BA; D'Andrea A; Bruder O; Cosyns B; Davin L; Donal E; Freitas A; Habib G; Kitsiou A; Petersen SE; Schroeder S; Lancellotti P; Camici P; Dulgheru R; Hagendorff A; Lombardi M; Muraru D; Sicari R Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):280. PubMed ID: 25650407 [TBL] [Abstract][Full Text] [Related]
19. [Assessment of ischemic heart disease with electron-beam CT and MR imaging]. Nakanishi T; Ito K Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):647-55. PubMed ID: 10565166 [TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging in hypertrophic cardiomyopathy (preliminary experience of 6 cases)]. Zhang L Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):13-4, 60-1. PubMed ID: 2397688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]